Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tommaso Rozera
Observed names:
T Rozera,
T. Rozera
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0003-4253-8311
Observed ORCID:
0000-0003-4253-8311
OpenAlex ID:
A5077865908
Machine Learning and Artificial Intelligence in the Multi-Omics Approach to Gut Microbiota
2025
·
Tommaso Rozera
, Edoardo Pasolli
, et al.
·
Gastroenterology
·
146
PDF
From big data and experimental models to clinical trials: Iterative strategies in microbiome research
2025
·
Sondra Turjeman
, Tommaso Rozera
, et al.
·
Cell
·
58
Histamine-producing bacteria and their role in gastrointestinal disorders
2023
·
Marcello Fiorani
, Livio Enrico Del Vecchio
, et al.
·
Expert Review of Gastroenterology & Hepatology
·
41
The Role of Microbiota in Pancreatic Cancer
2023
·
Valerio Papa
, Tommaso Schepis
, et al.
·
Cancers
·
28
PDF
Validation Study of the Richards-Campbell Sleep Questionnaire in Patients with Acute Stroke
2022
·
Eleonora Rollo
, Giacomo Della Marca
, et al.
·
Journal of Personalized Medicine
·
22
PDF
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study
2024
·
Debora Rondinella
, Gianluca Quaranta
, et al.
·
Microbes and Infection
·
21
The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
2025
·
Andrea Severino
, Serena Porcari
, et al.
·
Biomedicines
·
7
PDF
Review Article: Green Management of IBD —New Paradigms for an Eco‐Friendly Approach
2024
·
Giovanni Cammarota
, Lucrezia Laterza
, et al.
·
Alimentary Pharmacology & Therapeutics
·
6
Clinical Value of Ultrasound Fat Fraction in Grading Hepatic Steatosis: Preliminary Cut-Off Values in Obese Patients
2025
·
Francesca Ibba
, Carlo Airola
, et al.
·
Gastroenterology Insights
·
1
PDF
A cecal lesion hiding a secret: underwater endoscopic mucosal resection revealed an occult appendiceal neuroendocrine tumor
2026
·
Rossella Maresca
, Tommaso Schepis
, et al.
·
Endoscopy
PDF
Performance of the Limoges Bleeding Score in Predicting Delayed Bleeding After Colorectal ESD: A Retrospective Study
2026
·
T Rozera
, F Barbaro
, et al.
·
Endoscopy
Junctional versus non-junctional Barrett’s esophagus-derived adenocarcinoma: histopathological features and outcomes of Endoscopic Submucosal Dissection (ESD)
2026
·
S Pecere
, G Piccirilli
, et al.
·
Endoscopy
A cecal lesion hiding a secret: Underwater EMR revealed an occult appendiceal neuroendocrine tumor
2026
·
F Barbaro
, T Schepis
, et al.
·
Endoscopy
Efficacy and Safety of Endoscopic Submucosal Dissection in the Treatment of Superficial Gastric Neoplasia: Interim Analysis of a Prospective Multicenter National Registry (SIED)
2026
·
F Barbaro
, S A Marchitto
, et al.
·
Endoscopy
Endoscopy as an ‘organ-preserving’ strategy: the Italian experience in endoscopic submucosal dissection (ESD) of ileocecal valve lesions
2026
·
F Barbaro
, R Maresca
, et al.
·
Endoscopy
Mitigating risk following upper gastrointestinal Endoscopic Submucosal Dissection: preventing bleeding, perforation and stricture formation
2026
·
Giulio Calabrese
, Rossella Maresca
, et al.
·
Best Practice & Research Clinical Gastroenterology
A double-blind, randomized, placebo-controlled, single-center, pilot study evaluating the role of a L. rhamnosus GG-based symbiotic formulation in patients with mild-to-moderate uc in clinical and endoscopic remission
2025
·
L. Lopetuso
, M. Murgiano
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Oc.14.5 Therapeutic Modulation of Gut Microbiome to Treat Immune-checkpoint Inhibitors-related Diarrhea and Colitis: Experience of a Microbiome Clinic
2025
·
S. Porcari
, F. Deutschbein
, et al.
·
Digestive and Liver Disease
Oc.20.1 a Double-blind, Randomized, Placebo-controlled, Single-center, Pilot Study Evaluating the Efficacy of Prolactis® Gg Plus in Modulating Gut Microbiota Biodiversity in Patients With Mild-to-moderate Uc in Clinical and Endoscopic Remission
2025
·
B. Bartocci
, M. Murgiano
, et al.
·
Digestive and Liver Disease
Oc.19.3 Clinical Relevance of Positive Molecular Stool Testing for Intestinal Pathogens in Different Gastrointestinal Disorders
2025
·
T. Rozera
, P. Frasca
, et al.
·
Digestive and Liver Disease
P0896 A double-blind, randomized, placebo-controlled, single-center, pilot study evaluating the efficacy of a synbiotic formulation in modulating gut microbiota biodiversity in patients with mild-to-moderate UC in clinical and endoscopic remission
2025
·
M Murgiano
, B Bartocci
, et al.
·
Journal of Crohn s and Colitis
PDF
Boc.01.7: Efficacy and Safety of Fecal Microbiota Transplantation for the Treatment of Severe and Severe-complicated Clostridioides Difficile Infection: Report From a Large-volume Fmt Center
2024
·
G. Ianiro
, L. Masucci
, et al.
·
Digestive and Liver Disease
T.06.3: Prevalence Of, and Microbial Risk Factors For, Irritable Bowel Syndrome and Functional Dyspepsia After Acute Gastrointestinal Infection: a Systematic Review and Meta-analysis
2024
·
S. Porcari
, M.R. Ingrosso
, et al.
·
Digestive and Liver Disease
T.06.8: a Microbiome Testing-based Precision Medicine Approach to Treat Post-infectious Irritable Bowel Syndrome: a Pilot Study
2024
·
W. Fusco
, E. Tohumcu
, et al.
·
Digestive and Liver Disease
Oc.04.6: Screening of Donor Feces With a Direct Stool Testingbased Approach: Framework and Outcomes of a Largevolume Donor Stool Biobank for Fecal Microbiota Transplantation
2024
·
D. Rondinella
, G. Quaranta
, et al.
·
Digestive and Liver Disease
Show more works
View as search
Works count:
28
Citation count:
330
H-index:
7
I10-index:
6
Year
Topic
Type